We have a long-standing commitment to data transparency. Since the company was formed in 2009, we have been disclosing our clinical research data and sharing our information from ViiV clinical trials.
We recognise that transparency in research is fundamental to accelerate scientific progress in developing innovative new HIV treatments. To this end, we have a clinical study register for sharing clinical trial information and data with the broader academic and research community working in HIV.
Protocol summaries, result postings and anonymised clinical data
When interventional studies involving human subjects are initiated, protocol summaries of ViiV Healthcare-sponsored studies are posted on our clinical study register. In addition, the ViiV Healthcare clinical study register provides an easily accessible repository of data from ViiV Healthcare-sponsored clinical studies and includes the following information:
- Protocol summaries for ongoing studies (i.e., a brief description of what is being researched and what the study is designed to investigate)
- Results from completed clinical studies on approved medicines
- Results of observational research (studies of ViiV Healthcare medicines)
We submit the results of interventional human subject research studies as comprehensive manuscripts for publication in peer-reviewed journals that are indexed by online search engines.
We register ViiV Healthcare-sponsored clinical trials on external registries as required by current regulation through http://www.clinicaltrials.gov/ and https://www.clinicaltrialsregister.eu.
We share anonymised Individual Patient Data (IPD) and redacted Clinical Study Reports (CSRs) via https://clinicalstudydatarequest.com/Study-Sponsors-ViiV-Details.aspx.
For more information please contact:
Email: ViiV Healthcare Global Communications
Tel: +44 (0) 208 380 6200
NP-GBL-HVX-COCO-220045 March 2022
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.